C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Rigel Awarded $16.5 Million from U.S. Department of Defense for Phase 3 Clinical Trial of Fostamatinib in COVID-19 Patients

Saturday, January 30, 2021

Rigel Pharmaceuticals Inc announced it has been awarded million by the US Department of Defenses DOD Joint Program Executive Office for Chemical Biological Radiological and Nuclear Defense JPEOCBRND

Hoth Therapeutics Expands Research Collaboration Agreement with Weill Cornell Medicine to Continue the Advancement of HT-003 for Acne Treatment Research

Friday, January 29, 2021

Hoth Therapeutics Inc a biopharmaceutical company today announced extending a research collaboration agreement with Weill Cornell Medicine to continue investigating the therapeutic mechanism of action and safety of HT a novel retinoic acid metabolism...

Lilly and Asahi Kasei Pharma Announce License Agreement for Chronic Pain Drug Candidate

Friday, January 29, 2021

Eli Lilly and Company and Asahi Kasei Pharma Corporation announced a license agreement whereby Lilly will acquire the exclusive rights for AK from Asahi Kasei Pharma AK is an orally bioavailable PX receptor antagonist that recently completed Phase s...

AbCellera-Discovered Antibody, Bamlanivimab, to be Developed with VIR-7831 for the Treatment of COVID-19

Thursday, January 28, 2021

AbCellera announced that bamlanivimab LYCoV a human antibody discovered by AbCellera and developed with Eli Lilly and Company Lilly will be evaluated together with VIR an antibody developed by Vir Biotechnology Inc and GlaxoSmithKline

Cognate BioServices and Nucleus Biologics announce partnership in Cell and Gene Therapies

Thursday, January 28, 2021

Cognate BioServices Inc the premier commercialready global CDMO in the Cell and Gene Therapy industry and Nucleus Biologics LLC The Cell Performance Company announced a partnership for custom and commercial medias and delivery systems for Cell and Ge...

BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong for COVID-19 Vaccine

Wednesday, January 27, 2021

BioNTech SE and Shanghai Fosun Pharmaceutical Group Co Ltd announced that according to the Food and Health Bureau of the Hong Kong Special Administrative Region of the PRC Hong Kong the COVID vaccine COMIRNATY based on BioNTechs proprietary mRNA tech...

Agenus Enters into Clinical Collaboration with Nelum for Zalifrelimab Combination

Wednesday, January 27, 2021

Agenus Inc an immunooncology company with an extensive pipeline of checkpoint antibodies cell therapies adjuvants and vaccines designed to activate immune response to cancers and infections

Care Access Research Collaborates with AstraZeneca on Phase III Clinical Trial for COVID-19 Long-Acting Antibody Combination

Wednesday, January 27, 2021

Care Access Research a decentralized research organization DRO that operates as one connected team of physicians and research experts announced a collaboration with global biopharmaceutical company AstraZeneca to accelerate a clinical trial in the US

Menarini obtains European Commission approval for the use of ELZONRIS (tagraxofusp) in the treatment of plasmacetoid blast dendritic cell neoplasm (NCDPB)

Monday, January 25, 2021

The Menarini Group a privatelyheld Italian pharmaceutical and diagnostic company announced that it has been granted marketing authorization by the European Commission for ELZONRIS tagraxofusp as a monotherapy for the firstline treatment of adult pati...

Mitsubishi Tanabe Pharma America and Aquestive Therapeutics Announce U.S. Licensing and Supply Deal for Riluzole Oral Film for ALS Treatment

Friday, January 22, 2021

Mitsubishi Tanabe Pharma America Inc MTPA and Aquestive Therapeutics Inc announced a licensing and supply deal for the US rights to commercialize EXSERVAN riluzole an oral film formulation of riluzole for the treatment of amyotrophic lateral sclerosi...

Latest Issue
Get instant
access to our latest e-book
Saving Money, Saving Time In Pharma Operations